Skip to main content
Premium Trial:

Request an Annual Quote

TurboWorx Gets Industry Optimized Status in IBM Partnering Program

NEW YORK, June 9 (GenomeWeb News) - TurboWorx has attained "industry optimized status" in IBM's PartnerWorld Industry Networks program, the companies said yesterday.


The development will help the workflow-management solutions company to "deliver customized solutions based on open standards to our customers in the life sciences industry, said Jeff Augen, TurboWorx president and CEO, in the statement.


IBM aids the delivery of Partnerworld Industry Networks members' products to market, and help shape these solutions to the specific needs of industries, the companies said.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.